Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
LIC MF Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.4692538519.8633
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.734667234.9317
Domestic EquitiesTorrent Pharmaceuticals Ltd.5.6805131304.8851
Domestic EquitiesCipla Ltd.5.5587312184.7804
Domestic EquitiesNeuland Laboratories Ltd.4.852824144.1733
Domestic EquitiesDivi's Laboratories Ltd.4.637961583.9885
Domestic EquitiesFortis Healthcare Ltd.4.4996421023.8696
Domestic EquitiesAurobindo Pharma Ltd.4.4649313013.8397
Domestic EquitiesPiramal Pharma Ltd.4.31871983853.7140
Domestic EquitiesAlkem Laboratories Ltd.3.407751552.9306
Domestic EquitiesAbbott India Ltd.3.38539682.9113
Domestic EquitiesNavin Fluorine International Ltd.3.198647962.7507
Domestic EquitiesOnesource Specialty Pharma Ltd.3.1545177052.7128
Domestic EquitiesArtemis Medicare Services Ltd.3.1046935292.6699
Domestic EquitiesIPCA Laboratories Ltd.2.8055166042.4127
Domestic EquitiesConcord Biotech Ltd.2.7506166872.3655
Domestic EquitiesGland Pharma Ltd.2.7317133512.3492
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.7144119942.3343
Domestic EquitiesMetropolis Healthcare Ltd.2.5635114172.2046
Domestic EquitiesDr Agarwal's Health Care Ltd.2.4563395762.1124
Domestic EquitiesMax Healthcare Institute Ltd.2.2682167751.9506
Domestic EquitiesMankind Pharma Ltd.2.245085771.9307
Domestic EquitiesGlobal Health Ltd.2.1663149521.8630
Domestic EquitiesSyngene International Ltd.2.1304282601.8321
Domestic EquitiesAcutaas Chemicals Ltd.1.773983021.5255
Domestic EquitiesAnthem Biosciences Ltd.1.6946229611.4573
Domestic EquitiesVinati Organics Ltd.1.605687411.3808
Domestic EquitiesLinde India Ltd.1.081515590.9301
Total 98.4551 84.6697
Cash & Cash Equivalents and Net AssetsTreps1.7840 1.5342
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.2391 -0.2056
Total 1.5449 1.3286
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.